RXi Pharmaceuticals Corporation:企業のM&A・事業提携・投資動向

◆英語タイトル:RXi Pharmaceuticals Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2116
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:128
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

RXi Pharmaceuticals Corporation – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s RXi Pharmaceuticals Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by RXi Pharmaceuticals Corporation since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes RXi Pharmaceuticals Corporation’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by RXi Pharmaceuticals Corporation. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on RXi Pharmaceuticals Corporation’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by RXi Pharmaceuticals Corporation and its subsidiaries since 2007.
- Information about key financial and legal advisors for RXi Pharmaceuticals Corporation’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about RXi Pharmaceuticals Corporation’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 7
LIST OF FIGURES 7
TARGETS AND PARTNERS 8
MERGERS & ACQUISITIONS 9
Mergers and Acquisitions – Overview 9
Mergers and Acquisitions – Deal reports 10
PARTNERSHIP 16
Partnership – Overview 16
Partnership – Deal reports 17
CAPITAL RAISING 78
Capital Raising – Overview 78
Capital Raising – Deal reports 79
DIVESTMENTS 108
Divestments – Overview 108
Divestments – Deal reports 109
PRIVATE EQUITY & OWNERSHIP 113
Private Equity and Ownership – Deal reports 113
APPENDIX 118
Contact Us 118
About MarketLine Financial Deals Database 118
Deal Definition and Methodology 120
About MarketLine 127

List of Tables
Table 1: RXi Pharmaceuticals Corporation M&A volume and value trend (2014-YTD2018)
Table 2: RXi Pharmaceuticals Corporation M&A activity by geography (2014-YTD2018)
Table 3: RXi Pharmaceuticals Corporation partnership volume and value trend (2014-YTD2018)
Table 4: RXi Pharmaceuticals Corporation partnership trend by key deal type (2014-YTD2018)
Table 5: RXi Pharmaceuticals Corporation capital raising volume and value trend (2014-YTD2018)
Table 6: RXi Pharmaceuticals Corporation capital raising by deal type (2014-YTD2018)
Table 7: RXi Pharmaceuticals Corporation divestments volume and value trend (2014-YTD2018)
Table 8: RXi Pharmaceuticals Corporation divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: RXi Pharmaceuticals Corporation M&A volume and value trend (2014-YTD2018)
Figure 2: RXi Pharmaceuticals Corporation M&A activity by geography (2014-YTD2018)
Figure 3: RXi Pharmaceuticals Corporation partnership volume and value trend (2014-YTD2018)
Figure 4: RXi Pharmaceuticals Corporation partnership trend by key deal type (2014-YTD2018)
Figure 5: RXi Pharmaceuticals Corporation capital raising volume and value trend (2014-YTD2018)
Figure 6: RXi Pharmaceuticals Corporation capital raising by deal type (2014-YTD2018)
Figure 7: RXi Pharmaceuticals Corporation divestments volume and value trend (2014-YTD2018)
Figure 8: RXi Pharmaceuticals Corporation divestments by geography (2014-YTD2018)

★海外企業調査レポート[RXi Pharmaceuticals Corporation:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Enel Green Power SpA:電力:M&Aディール及び事業提携情報
    Summary Enel Green Power SpA (EGP) a subsidiary of Enel SpA, is an energy company that is involved in developing and operating renewable projects. It generates power from wind, biomass, geothermal, solar, and hydropower sources. The company also has interests in various power plants in under constru …
  • Henry Lamotte Group:戦略・SWOT・企業財務分析
    Henry Lamotte Group - Strategy, SWOT and Corporate Finance Report Summary Henry Lamotte Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Imperial College London-製薬・医療分野:企業M&A・提携分析
    Summary Imperial College London (Imperial) is a research university that offers educational services. The university provides undergraduate and postgraduate courses. It offers courses in the field of science and technology, agriculture, business, the humanities, and medicine. It conducts clinical tr …
  • DBV Technologies SA (DBV):企業の財務・戦略的SWOT分析
    Summary DBV Technologies SA (DBV Technologies) is a biopharmaceutical company which develops self-administered and non-invasive therapies to treat food allergies and other immunological diseases. Its product pipeline includes Viaskin peanut, Viaskin milk and Viaskin egg indicated for the treatment o …
  • BJ’s Restaurants, Inc.:企業の戦略・SWOT・財務情報
    BJ's Restaurants, Inc. - Strategy, SWOT and Corporate Finance Report Summary BJ's Restaurants, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Seagen Inc (SGEN):企業の財務・戦略的SWOT分析
    Seagen Inc (SGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • BioMotiv LLC-製薬・医療分野:企業M&A・提携分析
    Summary BioMotiv LLC (BioMotiv) is a development company specializes in the licensing and development of therapeutics across wide disease areas including proteins, small molecules, antibodies, and nucleotides. The company in association with The Harrington Project for Discovery & Development acceler …
  • Virgin Media Inc:企業の戦略的SWOT分析
    Virgin Media Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Faroe Petroleum plc (FPM):企業の財務・戦略的SWOT分析
    Summary Faroe Petroleum Plc (Faroe Petroleum) is an oil and gas company that concentrates on exploration, appraisal, development and production opportunities. The company has its exploration and development assets in the UK. Its operations portfolio consists of exploration, appraisal, development an …
  • Informa PLC (INF):企業の財務・戦略的SWOT分析
    Informa PLC (INF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • bioMerieux SA (BIM):医療機器:M&Aディール及び事業提携情報
    Summary bioMerieux SA (bioMerieux), a subsidiary of Institut Merieux SA, develops, manufactures and markets in vitro diagnostic solutions for private and hospital laboratories. The company offers diagnostic solutions such as systems, reagents and software. Its products are used to diagnose infectiou …
  • Suzlon Energy Ltd (SUZLON):電力:M&Aディール及び事業提携情報
    Summary Suzlon Energy Ltd (Suzlon) is a provider of renewable energy solutions. It offers total solutions package that covers the entire wind energy projects scope. The company provides complete turnkey solutions from design to lifecycle asset management. Suzlon also generates electricity; and sells …
  • Physiotherapy Associates Inc-製薬・医療分野:企業M&A・提携分析
    Summary Physiotherapy Associates Inc (Physiotherapy Associates) is a healthcare service provider that offers physical therapy services. The center offers services such as aquatic therapy, disability evaluation, dry needling, hand therapy, neurologic rehabilitation, pediatric rehabilitation, TMJ diso …
  • Nippon Flour Mills Co., Ltd.
    Nippon Flour Mills Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nippon Flour Mills Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • CEL-SCI Corp (CVM):製薬・医療:M&Aディール及び事業提携情報
    Summary CEL-SCI Corp (CEL-SCI) is a biotechnology company that carries out the research and development of new immunotherapy products for the treatment of various cancer and infectious diseases. Its core capabilities include drug discovery, research, development and manufacturing of compound biologi …
  • Synthomer plc (SYNT):企業の財務・戦略的SWOT分析
    Synthomer plc (SYNT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Genentech, Inc.:企業の戦略・SWOT・財務分析
    Genentech, Inc. - Strategy, SWOT and Corporate Finance Report Summary Genentech, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • PT Pudjiadi Prestige Tbk:企業の戦略・SWOT・財務情報
    PT Pudjiadi Prestige Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Pudjiadi Prestige Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Shinhan Bank:企業のM&A・事業提携・投資動向
    Shinhan Bank - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Shinhan Bank Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • OGK-2 (OGKB):企業の財務・戦略的SWOT分析
    OGK-2 (OGKB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆